HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D G Albertson Selected Research

Complementary DNA (cDNA)

1/2008Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D G Albertson Research Topics

Disease

3Neoplasms (Cancer)
02/2009 - 02/2001
2Carcinoma (Carcinomatosis)
09/2007 - 12/2001
1Neuroblastoma
01/2008
1Carcinogenesis
06/2006
1Neurofibromatosis 2 (Neurofibromatosis Type II)
02/2001

Drug/Important Bio-Agent (IBA)

1Transcription Factors (Transcription Factor)IBA
02/2009
1A-Form DNA (A-DNA)IBA
01/2008
1Complementary DNA (cDNA)IBA
01/2008
1RacivirIBA
09/2007
1Biomarkers (Surrogate Marker)IBA
06/2006
1Insulin (Novolin)FDA Link
12/2001
1Polyomavirus Transforming AntigensIBA
12/2001
1Neurofibromin 2 (Merlin)IBA
02/2001
1DNA (Deoxyribonucleic Acid)IBA
02/2001

Therapy/Procedure

1Precision Medicine
01/2008
1Ligation
09/2007